LWANC
CVS icon

Laurel Wealth Advisors (North Carolina)’s CVS Health CVS Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-205
Closed -$16.3K – 296
2025
Q4 		$16.3K Buy
+205
New +$16.2K ﹤0.01% 437
2025
Q2 		– Sell
-105
Closed -$7.11K – 298
2025
Q1 		$7.11K Hold
105
– – ﹤0.01% 509
2024
Q4 		$4.71K Hold
105
– – ﹤0.01% 560
2024
Q3 		$6.6K Sell
105
-379
-78% -$22.1K ﹤0.01% 487
2024
Q2 		$28.6K Sell
484
-10
-2% -$626 0.01% 345
2024
Q1 		$39.4K Sell
494
-39
-7% -$2.98K 0.01% 316
2023
Q4 		$42.1K Hold
533
– – 0.01% 294
2023
Q3 		$37.2K Sell
533
-200
-27% -$14.2K 0.01% 303
2023
Q2 		$50.7K Sell
733
-1,474
-67% -$105K 0.01% 282
2023
Q1 		$164K Buy
2,207
+2,003
+982% +$168K 0.03% 186
2022
Q4 		$19K Hold
204
– – ﹤0.01% 337
2022
Q3 		$19K Sell
204
-1,082
-84% -$107K ﹤0.01% 334
2022
Q2 		$119K Sell
1,286
-300
-19% -$29.3K 0.03% 193
2022
Q1 		$161K Sell
1,586
-742
-32% -$77.9K 0.03% 189
2021
Q4 		$240K Buy
2,328
+4
+0.2% +$370 0.05% 152
2021
Q3 		$197K Buy
2,324
+1,459
+169% +$122K 0.04% 166
2021
Q2 		$72K Buy
865
+4
+0.5% +$328 0.02% 245
2021
Q1 		$65K Buy
861
+54
+7% +$3.93K 0.02% 245
2020
Q4 		$55K Buy
807
+6
+0.7% +$390 0.01% 254
2020
Q3 		$47K Buy
801
+6
+0.8% +$373 0.01% 243
2020
Q2 		$52K Buy
795
+712
+858% +$44.8K 0.02% 231
2020
Q1 		$5K Hold
83
– – ﹤0.01% 408
2019
Q4 		$6K Hold
83
– – ﹤0.01% 426
2019
Q3 		$5K Hold
83
– – ﹤0.01% 424
2019
Q2 		$5K Hold
83
– – ﹤0.01% 432
2019
Q1 		$4K Sell
83
-100
-55% -$6.17K ﹤0.01% 418
2018
Q4 		$12K Buy
+183
New +$13.7K ﹤0.01% 333

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s CVS Position: Q1 2026 in Review

Laurel Wealth Advisors (North Carolina) sold out of CVS Health (CVS) in Q1 2026, closing a stake of 205 shares — an estimated $16.3K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in CVS in Q4 2018 and held it in 27 quarters. The position peaked at $240K in Q4 2021. 1,880 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Laurel Wealth Advisors (North Carolina) reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 205 CVS Health shares in Q1 2026, an estimated $16.3K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in CVS Health in Q4 2018 and held it in 27 quarters.
  • Laurel Wealth Advisors (North Carolina)'s CVS Health position peaked at $240K in Q4 2021.
  • 1,880 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 13 May 2026.